Valproate Sodium Injection — FDA Drug Shortage

Current — Fresenius Kabi USA, LLC

The FDA lists a drug shortage record for Valproate Sodium Injection (injection) from Fresenius Kabi USA, LLC with status Current. The shortage was first posted on 12/30/2020.

Shortage Details

Status
Current
Company
Fresenius Kabi USA, LLC
Package NDC
63323-494-05
Dosage Form
Injection
Presentation
Valproate Sodium, Injection, 100 mg/1 mL (NDC 63323-494-05)
Initial Posting
12/30/2020
Revised Date